Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03458247
Title Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer (OPTIMABI)
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hopitaux de Paris
Indications

prostate adenocarcinoma

Therapies

Abiraterone

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.